EMA adopted a positive opinion for Sobi's drug, with the European Commission set to confirm the decision.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
EMA adopted a positive opinion for Sobi's drug, with the European Commission set to confirm the decision.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
sobi
German beverage store chain
Nothing else this week.
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
-
European Commission
executive branch of the European Union
Related events
- Alvotech submitted a regulatory application to the European Medicines Agency (EMA).
- IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.
- PolyPid Ltd's product received FDA Priority Review and gained single authorization across EU states from the EMA.